Facets
Browse across eight MeSH (opens in new tab) facets — era, geography, science, specialty, technology, history, culture, and reference. Select one tag per group; counts update across the others.
Clear filtersFacet filters
Geography
Specialties & Disease
- Anatomy & Pathology 0
- Cardiology & Blood 0
- Neurology & Psychiatry 2
- Obstetrics & Reproductive 2
- Infectious Disease (General) 0
- Surgery & Anesthesia 0
- Public Health 7
- Immunology & Dermatology 3
- General Clinical Medicine 3
- Military Medicine 2
- Psychology 0
- Alternative & Fringe Medicine 2
- Pediatrics 3
- Ophthalmology & Vision 0
- ENT & Hearing 0
- Urology & Nephrology 0
- Gastroenterology & Hepatology 0
- Pulmonary & Respiratory 0
- Rheumatology, Rehab & Pain 0
- Internal, Emergency & Geriatric 2
- Veterinary Medicine 1
- Epidemiology & Demography 1
- Physiology & Embryology 7
- Dentistry 0
- Plagues & Epidemics 4
- Microbiology & Virology 10
Social & Historical Studies
Institutions & Culture
Reference & Scholarly Works
Drugs & Technology
3 entries match Immunology & Dermatology [C19 / C20 / C17] · Zoology & Animal Sciences [K01.900.500.750] · Women & Gender [K01.700.500]
2007 CE
#11843
CRISPR provides acquired resistance against viruses in prokaryotes.
Horvath and his team provided key details of the extremely complex mechanisms involved in CRISPR's function as an immune system for bacteria against bacteriophages. Analogous to Pasteur's heroic role in saving the Fre…
2015 CE
#11848
Gene-edited pigs are protected from porcine reproductive and respiratory syndrome virus.
Order of authorship in the original publication: Whitworth, Rowland, Ewen, ... Prather. Using the CRISPR Cas molecular gene-editing tool, Prather and colleagues edited the gene that codes for the CD163 protein in adul…
2005 CE
#13622
Suppression of RNA recognition by toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA.
Karikó and Weissman discovered the nucleoside modifications that suppress the immungenicity of RNA, leading to their patents for the application of non-immunogenic, nucleoside-modified RNA (modRNA). This techno…